Therapy with autologous adipose-derived... (2013 study) Skip to main content
Clinical Trial J Surg Res 2013

Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease

Marino G, Moraci M, Armenia E, Orabona C, Sergio R, De Sena G, et al., J Surg Res, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers injected a patient's own fat-derived stem and regenerative cells around the edges of long-lasting leg ulcers in people with poor blood flow to the legs.

What They Found

In a small clinical trial of 20 patients with peripheral arterial disease and chronic leg ulcers, of whom 10 were treated with autologous adipose-derived regenerative cells (ADRCs), every treated patient had a smaller and shallower ulcer, and six of the 10 had complete healing. Patients were followed at 4, 10, 20, 60 and 90 days. Treated patients also had less ulcer-related pain. The abstract reports no adverse events linked to the technique. Cell testing showed the injected product contained adipose-derived stem cells, and the authors state that ulcer closure was due to the cells and not to growth factors in the extract.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy or describe its use in this study, so it offers no information on HBOT for leg ulcers. It covers a cell-based procedure in a small group of people with poor leg circulation and chronic ulcers. Anyone with a leg ulcer should discuss treatment options with their own care team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Only 10 patients were treated, the abstract does not report a statistical comparison with the untreated patients, and it describes results up to 90 days, so the findings are preliminary.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Wound Care
Source Pubmed
PubMed ID 23773718
Year Published 2013
Journal J Surg Res
MeSH Terms Adipose Tissue; Aged; Ankle Brachial Index; Chronic Disease; Combined Modality Therapy; Female; Flow Cytometry; Graft Survival; Humans; Hyperbaric Oxygenation; Leg Ulcer; Male; Middle Aged; Peripheral Arterial Disease; Regeneration; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology